한빛사 논문
Yoosoo Chang, MD, PhD1-3, Yong Kyun Cho, MD, PhD4,*, Juhee Cho, PhD1,3,5, Hyun-Suk Jung, MD1, Kyung Eun Yun, MD, PhD1, Jiin Ahn, MSPH1, Chong Il Sohn, MD, PhD4, Hocheol Shin, MD, PhD1,6 and Seungho Ryu, MD, PhD1-3,*
1Center for Cohort Studies, Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea; 2Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea; 3Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea; 4Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea; 5Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health,Baltimore,Maryland, USA; 6Department of Family Medicine, Kangbuk SamsungHospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Correspondence: Seungho Ryu, MD, PhD., Yong Kyun Cho, MD, PhD.
Abstract
OBJECTIVES:
We compared liver-related mortality by fibrosis severity between 2 types of fatty liver disease (FLD), nonalcoholic FLD (NAFLD) and alcoholic FLD (AFLD), in a large cohort of nonobese and obese individuals.
METHODS:
A cohort study was performed with 437,828 Korean adults who were followed up for up to 14 years. Steatosis was diagnosed based on ultrasonography; fibrosis severity was determined by the fibrosis 4 (FIB-4) score. Vital status and liver-related deaths were ascertained through linkage to national death records.
RESULTS:
The prevalence of NAFLD and AFLD was 20.9% and 4.0%, respectively. During 3,145,541.1 person-years of follow-up, 109 liver-related deaths were identified (incidence rate of 3.5 per 105 person-years). When changes in fatty liver status, FIB-4 scores, and confounders during follow-up were updated as time-varying covariates, compared with the reference (absence of both excessive alcohol use and FLD), the multivariable-adjusted hazard ratios with 95% confidence intervals for liver-related mortality among those with low, intermediate, and high FIB-4 scores were 0.43 (0.19?0.94), 2.74 (1.23?6.06), and 84.66 (39.05?183.54), respectively, among patients with NAFLD, whereas among patients with AFLD, the corresponding hazard ratios (95% confidence intervals) were 0.67 (0.20?2.25), 5.44 (2.19?13.49), and 59.73 (27.99?127.46), respectively. The associations were more evident in nonobese individuals than in obese individuals (P for interaction = 0.004).
CONCLUSIONS:
In this large cohort of young and middle-aged individuals, NAFLD and AFLD with intermediate to high fibrosis scores were associated with an increased risk of liver-related mortality in a dose-dependent manner, especially among nonobese individuals.
논문정보
관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기